Entrada Therapeutics
Presence
Entrada Therapeutics is one of the...
Entrada Therapeutics is a company listed under the stock ticker TRDA (US).
Executives
View the org chart displaying its 14 main executives
Most searched biographies at Entrada Therapeutics
Popular executive movements at Entrada Therapeutics
- Nathan Dowden, who was Chief Operating Officer, is promoted to President and Chief Operating Officer (posted on January 4 2024).
Create your alert
to follow the executive moves at Entrada Therapeutics.
Biotechnology
Entrada Therapeutics has 2,297 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Actuate Therapeutics has just announced a $50 Million fundraising (posted on May 29 2024).
- Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).
- AbbVie has acquired Landos Biopharma (posted on May 25 2024).
Popular contacts in Biotechnology
News
Press releases by Entrada Therapeutics
- LinkedIn Login, Sign in | LinkedIn
- Entrada Therapeutics | Entrada Therapeutics Announces Collaboration with the Myotonic Dystrophy Clinical Research Network to Study the Natural History of Myotonic Dystrophy Type 1
- Log in or sign up to view
- Entrada Therapeutics | Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer
- LinkedIn Login, Sign in | LinkedIn
- Log in or sign up to view
- Entrada Therapeutics | Entrada Therapeutics to Present at William Blair Biotech Focus Conference
- LinkedIn Login, Sign in | LinkedIn
- Entrada Therapeutics | Entrada Therapeutics to Present at Goldman Sachs Global Healthcare Conference
- LinkedIn Login, Sign in | LinkedIn
- View more press releases Close
Social media about Entrada Therapeutics
- Entrada Therapeutics on Wikipedia, Google News & Yahoo Finance
- Entrada Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Gina Chapman 
Call Entrada Therapeutics at +1 646...
